Abstract
Two genes predisposing females to autosomal dominant breast cancer are located on chromosome 17. Mutations in the p53-gene on the short arm have been shown to predispose females to early onset breast cancer in families with the rare Li-Fraumeni syndrome. Another locus on 17q (BRCA1), was found to be linked to the disease in a subset of families with breast cancer. In order to determine the involvement of tumour suppressor genes at these loci in tumour development, we studied allele losses for markers on chromosome 17 in 78 familial breast carcinomas. The analysis used six polymorphic DNA markers, three on each arm. We found support for at least four separate regions displaying allele losses on chromosome 17: the p53-region, the distal part of 17p, the BRCA1 region and the distal part of 17q. The frequency of allele losses on distal 17p (16%) is low in these familial tumours compared with the previously reported incidence in sporadic tumours (>50%), whereas the frequency of losses at the p53 locus and on 17q was similar to sporadic tumours (5%–40%). These data suggest that several regions on chromosomal 17 can harbour tumour suppressor genes involved in tumour development of familial breast cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Børresen A-L (1992) Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 4:113–121
Bergerheim U, Nordenskjöld M, Collins VP (1989) Deletion mapping in renal cell carcinoma. Cancer Res 49:1390–1396
Børresen A-L, Ottestad L, Gaustad A, Andersen TI, Heikkilä R, Jansen T, Tveit KM, Nesland JM (1990) Amplification and protein over-expression of the neu/HER-2/c-erbB2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis. Br J Cancer 62:585–590
Børresen A-L, Hovig E, Smith-Sørensen B, Malkin D, Lystad S, Andersen TI, Nesland JM, Isselbacher KJ, Friend SH (1991) Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA 88:8405–8409
Børresen A-L, Andersen TI, Garber J, Barbier N, Thorlacius S, Eyfjord J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, Friend SH (1992) Screening for TP53 germ line mutations in breast cancer patients. Cancer Res 52:3234–3236
Cavenee WK, Hansen MF, Nordenskjöld M, Kock E, Maumenee I, Squire JA, Phillips RA, Gallie BL (1985) Genetic origin of mutations predisposing to retinoblastoma. Science 228:501–503
Coles C, Thompson AM, Elder PA, Cohen BB, Machenzie IM, Macdonald M, Nakamura Y, Hoyheim B, Steel CM (1990) Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet 336:761–763
Cropp CS, Lidereau R, Campell G, Champene MH, Callahan R (1990) Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. Proc Natl Acad Sci USA 87:7737–7741
Devilee P, Cornelisse CJ, Kuipers-Dijkshoorn N, Jonker C, Pearson PL (1990) Loss of heterozygosity on 17p in human brest carcinomas: defining the smallest common region of deletion. Cytogenet Cell Genet 53:52–54
Devilee P, Vliet M van, Sloun P van, Kuipers-Dijkshoorn N, Hermans J, Pearson PL, Cornelisse CJ (1991). Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6:1705–1711
Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium (1992) Genetic linkage analysis in familial breast and ovarian cancer — results from 214 families. Am J Hum Genet (in press)
Fromentel CC de, Soussi T (1992) TP53 Tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer 4:1–15
Hall JM, Newman B, Morrow JE, Andersson LA, Huey B, King M-C (1991) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684–1690
Hall JM, Friedman L, Guenther C, Lee MK, Weber JL, Black DM, King M-C (1992) Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50:1235–1242
Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49–51
Huang H-JS, Yee J-K, Shew JY, Chen P-L, Boostein R, Friedmann T, Lee E, Lee W-H (1988) Suppression of the neoplastic phenotype by replacement of the Rb gene in human cancer cells. Science 242:1563–1566
Knudson AG (1978) Retinoblastoma: a prototypic hereditary neoplasm. Semin Oncol 5:57–60
Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85–87
Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M (1990) Genomic alterations in human breast carcinomas. Genes Chromosomes Cancer 2:191–197
Li FP, Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer and other neoplasms a familial syndrome? Ann Intern Med 71:747–752
Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275–281
Lynch HT, Watson P, Lynch JF (1989) Epidemiology and risk factors (breast cancer and the gynecologist). Clin Obstret Gynecol 32:750–760
Mackay JM, Steel CM, Elder PA, Forrest APM, Evans HJ (1988) Allele loss on short arm of chromosome 17 in breast cancers. Lancet II:1384–1385
Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238
Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, Lenoir GM (1991) Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338:82–83
Prosser J, Elder PA, Condie A, Macfadyen I, Steel CM, Evans HJ (1991) Mutations in p53 do not account for heritable breast cancer: a study in five affected families. Br J Cancer 63:181–184
Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM, Evans HJ (1992) Constitutional p53 mutation in a nonLi-Fraumeni cancer family. Br J Cancer 65:527–528
Rouleau GA, Werteleckl W, Haines JL, Hobbs WJ, Trofatter JA, Seizinger BR, Martuza RL, Superneau DW, Conneally PM, Gusella F (1987) Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature 329:246–248
Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y (1990) Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184–7189
Seizinger BR, Rouleau G, Ozelius LJ, Lane AH, Farmer GE, St George-Hyslop P, Huson S, Gusella JF, Martuza R (1987) Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science 236:317–319
Seizinger BR, Rouleau G, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JWM, Collins D, Majoor-Krakauer D, Bonner T, Mathew C, Rubenstein A, Halpering J, Mcconkie-Rosell A, green JS, Trofatter JA, Ponder BA, Eierman L, Bowmer MI, Schimke R, Oostra B, Aronin N, Smith DI, Drabki H, Waziri MH, Hobbs WJ, Martuza RL, Coneally PM, Hsia YE, Gusella JF (1988) Von Hippel-Lindau disease maps to region of chromosome 3 associated with renal cell carcinoma. Nature 332:268–269
Sidransky D, Tokino T, Helzlsouer K, Rausch G, Zehnbauer B, Shelton B, Prestiglacomo L, Vogelstein B, Davidson N (1992) Inherited p53 mutations in breast cancer. Cancer Res 52:2984–2986
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith D, Ullrich A, Press MF (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712
Srivastava S, Zou Z, Pirollo K, Blattner W, Chang EH (1990) Germline transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348:747–749
Thompson AM, Steel CM, Chetty U, Hawkins RA, Miller WR, Carter DC, Forrest APM, Evans HJ (1990) p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer 61:74–78
Varesco L, Caligo MA, Simi P, Black DM, Nardini V, Casarino L, Rocchi M, Ferrara G, Solomon E, Bevilacqua G (1992) The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bg/ II. Genes Chromosomes Cancer 4:84–88
Williamson R, Bowcock A, Kidd K, Pearson P, Schmidtke J, Ceverha P, Chipperfield M, Cooper DN, Coutelle C, Hewitt J, Klinger K, Langley K, Beckmann J, Tolley M, Maidak B (1991) Report of the DNA committee and catalogues of cloned and mapped genes, markers formatted for PCR and DNA polymorphisms. Cytogenet Cell Genet 58:1190–1832
Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–531
Xu W, Mulligan LM, Ponder MA, Liu L, Smith BA, Mathew CGP, Ponder BAJ (1992) Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 4:337–342
Zbar B, Brauch H, Talmadge C, Lineham M (1987) Loss of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 327:721–724
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lindblom, A., Skoog, L., Andersen, T.I. et al. Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas. Hum Genet 91, 6–12 (1993). https://doi.org/10.1007/BF00230213
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00230213